Radyus Research
Alan Frey currently serves as the Chief Scientific Officer at Cambium Oncology since June 2021. Prior to this role, Alan Frey was a professor of cell biology at NYU Grossman School of Medicine from August 1988 until February 2020.
This person is not in the org chart
This person is not in any offices
Radyus Research
Radyus Research is a collaborative research organization, offering a wide range of preclinical drug development services combined with comprehensive scientific and strategic consulting.